APA (7th ed.) Citation

Wu, Y. L., Cappuyns, S., Loh, A., Sun, S., Lewis, S., Sung, M. W., . . . Cohen, D. J. (2024). Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors. BJC Reports, 2(1), . https://doi.org/10.1038/s44276-024-00038-w

Chicago Style (17th ed.) Citation

Wu, Y. Linda, Sarah Cappuyns, Amanda Loh, Sean Sun, Sara Lewis, Max W. Sung, Myron Schwartz, Josep M. Llovet, and Deirdre J. Cohen. "Impact of Underlying Liver Disease on Unresectable Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors." BJC Reports 2, no. 1 (2024). https://doi.org/10.1038/s44276-024-00038-w.

MLA (9th ed.) Citation

Wu, Y. Linda, et al. "Impact of Underlying Liver Disease on Unresectable Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors." BJC Reports, vol. 2, no. 1, 2024, https://doi.org/10.1038/s44276-024-00038-w.